CA1251442C - - Google Patents

Info

Publication number
CA1251442C
CA1251442C CA 432584 CA432584A CA1251442C CA 1251442 C CA1251442 C CA 1251442C CA 432584 CA432584 CA 432584 CA 432584 A CA432584 A CA 432584A CA 1251442 C CA1251442 C CA 1251442C
Authority
CA
Canada
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA 432584
Other versions
CA1230115A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/507,961 external-priority patent/US4556654A/en
Application filed filed Critical
Priority to CA000550175A priority Critical patent/CA1251442A/en
Priority to CA000550174A priority patent/CA1256431A/en
Priority to CA000550173A priority patent/CA1248097A/en
Publication of CA1230115A publication Critical patent/CA1230115A/en
Application granted granted Critical
Publication of CA1251442C publication Critical patent/CA1251442C/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/02—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic ring being only condensed in peri position
    • C09B5/16—Benz-diazabenzanthrones, e.g. anthrapyrimidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000432584A 1982-07-23 1983-07-18 ANTHRA[1,9-CD]PYRAZOL-6(2H)-ONES SUBSTITUTES Expired CA1230115A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA000550175A CA1251442A (en) 1982-07-23 1987-10-23 Intermediates for substituted anthra¬1,9-cd|- pyrazol-6(2h)-ones
CA000550174A CA1256431A (en) 1982-07-23 1987-10-23 Substituted anthra¬1,9-cd|pyrazol-6-(2h)-ones
CA000550173A CA1248097A (en) 1982-07-23 1987-10-23 Intermediates for substituted anthra¬1-9-cd|- pyrazol-6(2h)-ones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40115782A 1982-07-23 1982-07-23
US06/507,961 US4556654A (en) 1983-06-28 1983-06-28 Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000550173A Division CA1248097A (en) 1982-07-23 1987-10-23 Intermediates for substituted anthra¬1-9-cd|- pyrazol-6(2h)-ones

Publications (2)

Publication Number Publication Date
CA1230115A CA1230115A (en) 1987-12-08
CA1251442C true CA1251442C (da) 1989-03-21

Family

ID=27017319

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000432584A Expired CA1230115A (en) 1982-07-23 1983-07-18 ANTHRA[1,9-CD]PYRAZOL-6(2H)-ONES SUBSTITUTES

Country Status (18)

Country Link
EP (1) EP0103381B1 (da)
JP (2) JPH072719B2 (da)
KR (1) KR900005026B1 (da)
AR (1) AR240315A1 (da)
AU (1) AU549659B2 (da)
CA (1) CA1230115A (da)
DE (1) DE3373811D1 (da)
DK (3) DK159429C (da)
ES (3) ES8504731A1 (da)
FI (1) FI82932C (da)
GR (1) GR79610B (da)
HU (1) HU195779B (da)
IE (1) IE56782B1 (da)
IL (1) IL69211A (da)
NO (1) NO160000C (da)
NZ (1) NZ205001A (da)
PH (1) PH20906A (da)
PT (1) PT77088B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251451A (en) * 1984-06-29 1989-03-21 Ellen M. Berman Benzoseleno¬4,3,2-cd|indazole compositions and methods for their production and use
CA1251450A (en) * 1984-06-29 1989-03-21 David B. Capps Benzopyrano¬4,3,2-cd|indazole compositions and methods for their production and use
US4608439A (en) * 1985-04-26 1986-08-26 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
US4672129A (en) * 1986-05-05 1987-06-09 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
CZ288366B6 (en) * 1992-09-08 2001-06-13 Univ Vermont 2-Aminoalkyl-5-aminoalkylamino substituted isoquinoindazol-6-(2H)-ones exhibiting antitumor activity, their use, pharmaceutical preparation in which they are comprised and process of their preparation
US5393886A (en) * 1993-05-05 1995-02-28 The Du Pont Merck Pharmaceutical Company Intermediates for the synthesis of anthrapyrazolone anticancer agents
US5596097A (en) * 1994-03-08 1997-01-21 The University Of Vermont Hetero-annulated indazoles
IT1277576B1 (it) * 1995-09-13 1997-11-11 Boehringer Mannheim Italia 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale
WO2008116161A2 (en) 2007-03-22 2008-09-25 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH191142A (de) * 1936-02-07 1937-05-31 Chem Ind Basel Verfahren zur Herstellung eines Anthrachinonderivates.
GB470475A (en) * 1936-02-14 1937-08-16 Of Chemical Industry Soc Manufacture of dyestuffs and intermediate products
US2518150A (en) * 1946-02-01 1950-08-08 Ciba Ltd Vat dyestuffs
DE2558812C2 (de) * 1975-12-27 1987-04-30 Hoechst Ag, 6230 Frankfurt Photopolymerisierbares Gemisch

Also Published As

Publication number Publication date
KR840005431A (ko) 1984-11-12
FI832638A0 (fi) 1983-07-20
DK329683D0 (da) 1983-07-18
AR240315A1 (es) 1990-03-30
KR900005026B1 (ko) 1990-07-18
NO160000B (no) 1988-11-21
DK329683A (da) 1984-01-24
FI82932B (fi) 1991-01-31
DK430389D0 (da) 1989-08-31
IL69211A0 (en) 1983-11-30
DE3373811D1 (en) 1987-10-29
GR79610B (da) 1984-10-31
EP0103381B1 (en) 1987-09-23
ES529578A0 (es) 1985-09-01
EP0103381A1 (en) 1984-03-21
JPH07179389A (ja) 1995-07-18
JPS5951268A (ja) 1984-03-24
JPH07110829B2 (ja) 1995-11-29
ES8507502A1 (es) 1985-09-01
PH20906A (en) 1987-05-27
NO160000C (no) 1989-03-01
DK430289A (da) 1989-08-31
AU549659B2 (en) 1986-02-06
FI82932C (fi) 1991-05-10
ES524380A0 (es) 1985-04-16
DK430289D0 (da) 1989-08-31
IE56782B1 (en) 1991-12-18
AU1681083A (en) 1984-01-26
HU195779B (en) 1988-07-28
IE831622L (en) 1984-01-23
DK159429B (da) 1990-10-15
ES8507503A1 (es) 1985-09-01
PT77088B (en) 1986-02-12
NO832659L (no) 1984-01-24
CA1230115A (en) 1987-12-08
DK159849B (da) 1990-12-17
JPH072719B2 (ja) 1995-01-18
ES8504731A1 (es) 1985-04-16
DK430389A (da) 1989-08-31
IL69211A (en) 1987-01-30
DK160251C (da) 1991-07-22
DK159849C (da) 1991-05-13
ES529577A0 (es) 1985-09-01
DK160251B (da) 1991-02-18
FI832638A (fi) 1984-01-24
DK159429C (da) 1991-03-18
NZ205001A (en) 1986-09-10
PT77088A (en) 1983-08-01

Similar Documents

Publication Publication Date Title
FR2519777B1 (da)
FR2520810B1 (da)
FR2521328B1 (da)
FR2519470B1 (da)
FR2522078B1 (da)
DE3347918A1 (da)
FR2521165B1 (da)
CH655502B (da)
FR2522341B1 (da)
FR2520466B1 (da)
FR2519784B1 (da)
FR2521788B1 (da)
FR2520804B1 (da)
DE3375436T (da)
CH655449B (da)
FR2520589B1 (da)
FR2519812B2 (da)
FR2521037B1 (da)
FR2520618B1 (da)
FR2521746B1 (da)
FR2519292B3 (da)
FR2522202B1 (da)
CH655583B (da)
FR2519595B1 (da)
FR2521305B1 (da)

Legal Events

Date Code Title Description
MKEX Expiry